Stereotaxis to Report Third Quarter 2015 Financial Results on November 3, 2015

ST. LOUIS, Oct. 27, 2015 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2015 third quarter ended September 30, 2015 on Tuesday, November 3, 2015 after the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the Company’s results and corporate developments.

What: Stereotaxis third quarter 2015 financial results conference call
   
When: Tuesday, November 3rd at 4:30 p.m. Eastern Time (1:30 p.m. PT)
   
Dial In Number: To access the live call, dial 877-876-9175 (US and Canada) or 785-424-1668 (International) and give the participant pass code 884437.
   
Webcast: To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at www.stereotaxis.com
   
Call Replay: A replay of the call will be available approximately one hour following the end of the call through 11:59 p.m. ET on Tuesday, November 10, 2015.
   
Replay Numbers: 888-203-1112 (US and Canada)
  719-457-0820 (International)
  Replay passcode: 884437

About Stereotaxis

Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. Over 100 issued patents support the Stereotaxis platform, which helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis’ core Epoch® Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive® robotic navigation system and consumables.

The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan, and elsewhere. The V-Sono ICE catheter manipulator, V-Loop variable loop catheter manipulator, and V-CAS catheter advancement system have received clearance in the United States, Canada, and the European Union. For more information, please visit www.stereotaxis.com.

CONTACT: Press Contact:	
Martin Stammer
Chief Financial Officer
314-678-6155	
				
Investor Contact:
Todd Kehrli / Jim Byers
MKR Group, Inc.
323-468-2300